98%
921
2 minutes
20
Background: Benign prostatic hyperplasia (BPH), as a cause of various lower urinary tract symptoms (LUTS), can improve patients' quality of life when effectively controlled. To elaborate on the effect of dietary calcium intake on BPH, we investigated the association between dietary calcium intake and the risk of BPH using data from the National Health and Nutrition Examination Survey (NHANES).
Methods: Data from the NHANES conducted from 2003 to 2008 were utilized. BPH was identified through self-reported questionnaires, and dietary calcium intake was calculated based on the mean of two 24-hour dietary recall interviews. Multivariable logistic regression analyses were performed to assess the association, supplemented by restricted cubic spline analysis and subgroup analyses.
Results: A total of 590 males aged 40 years and older were included in the study, of whom 138 had BPH. After adjusting for all covariates, a higher dietary calcium intake was associated with an increased risk of BPH [odds ratio (OR), 1.05; 95% confidence interval (CI): 1.01-1.09; P=0.04], and those without hypertension.
Conclusions: The study found a positive association between dietary calcium intake and the risk of BPH among U.S. men aged 40 years and older. High calcium intake may be associated with the occurrence of BPH, particularly in older individuals. These findings underscore the importance of monitoring dietary calcium intake as part of BPH prevention strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170208 | PMC |
http://dx.doi.org/10.21037/tau-2025-43 | DOI Listing |
J Affect Disord
September 2025
NHC Key Laboratory of Environment and Endemic Diseases, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Collaborative Innovation Center of Endemic Diseases and Health Promotion in Silk Road Region, Xi'an, Shaanxi, 710061, China. Electronic ad
Background: Evidence on the relationship between dietary minerals and mental disorders remains limited and inconsistent. This study assessed the associations between twelve essential minerals and six major mental disorders.
Methods: We included 199,877 participants from the UK biobank without implausible energy intake, missing covariates, or baseline mental disorders.
J Hum Nutr Diet
October 2025
Haszard Biostatistics, Otago, New Zealand.
Introduction: Dependent older adults in residential aged care are at increased risk of inadequate micronutrient intakes. Knowledge of dietary intakes in this group is needed to inform clinical decision making and guide nutrition policy and menu planning. This study aimed to determine the usual intake and food sources of micronutrients of New Zealand aged-care residents.
View Article and Find Full Text PDFMol Nutr Food Res
September 2025
The Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.
This study investigates the relationship between dietary antioxidants and heart failure (HF) risk using nationally representative National Health and Nutrition Examination Survey data (2005-2018). It aims to identify key dietary antioxidants and develop a machine-learning-based predictive model for HF. Among 9279 participants (434 HF cases), 44 dietary antioxidant variables were extracted from two 24-h dietary recalls.
View Article and Find Full Text PDFMedicine (Baltimore)
September 2025
Department of Orthopaedics, Beijing Ditan Hospital Affiliated to Capital Medical University, Beijing, China.
Osteoporosis is a common metabolic bone disease characterized by decreased bone density and increased fracture risk. Human immunodeficiency virus (HIV) infection is considered one of the independent risk factors for osteoporosis, but its specific mechanisms are not yet clear. This study aims to explore the relationship between HIV infection and osteoporosis based on the National Health and Nutrition Examination Survey database and to analyze the impact of related clinical factors on bone density.
View Article and Find Full Text PDFOsteoporos Int
September 2025
Department of Rheumatology, Univ. Lille, CHU Lille, MABlab ULR 4490, 59000, Lille, France.
Medications like liraglutide 3.0 mg daily (Saxenda®; Novo Nordisk) and semaglutide 2.4 mg weekly (Wegovy®; Novo Nordisk), which are glucagon-like peptide-1 receptor agonists (GLP-1Ra), have been sanctioned for prolonged weight management in people living with obesity (PwO).
View Article and Find Full Text PDF